Marshall Wace

Marshall Wace’s Cullinan Oncology CGEM Stock Holding History

Marshall Wace’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.9M	Buy	1,049,581 +635,222	+153%	+$8.16M	0.02%	807
2025 Q4	$4.29M	Buy	414,359 +118,917	+40%	+$1.07M	﹤0.01%	1222
2025 Q3	$1.75M	Sell	295,442 -331,139	-53%	-$2.43M	﹤0.01%	1681
2025 Q2	$4.72M	Buy	626,581 +58,582	+10%	+$471K	0.01%	1162
2025 Q1	$4.3M	Sell	567,999 -83,694	-13%	-$803K	0.01%	1136
2024 Q4	$7.94M	Sell	651,693 -402,071	-38%	-$5.78M	0.01%	882
2024 Q3	$17.6M	Sell	1,053,764 -130,273	-11%	-$2.31M	0.02%	551
2024 Q2	$20.6M	Buy	1,184,037 +1,136,993	+2,417%	+$24.2M	0.03%	491
2024 Q1	$802K	Buy	47,044 +13,670	+41%	+$211K	﹤0.01%	1742
2023 Q4	$340K	Buy	+33,374	New	+$296K	﹤0.01%	1851
2023 Q3	–	Sell	-10,837	Closed	-$117K	–	2259
2023 Q2	$117K	Buy	+10,837	New	+$115K	﹤0.01%	2310
2022 Q4	–	Sell	-40,576	Closed	-$520K	–	2995
2022 Q3	$520K	Sell	40,576 -2,547	-6%	-$34.3K	﹤0.01%	2706
2022 Q2	$553K	Buy	+43,123	New	+$489K	﹤0.01%	2744
2021 Q3	–	Sell	-74,951	Closed	-$1.93M	–	3073
2021 Q2	$1.93M	Buy	+74,951	New	+$2.3M	0.01%	1461

Other funds holding CGEM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return